A Randomized Phase II Trial of First-Line Treatment with Gemcitabine, Erlotinib, or Gemcitabine and Erlotinib in Elderly Patients (Age ≥70 Years) with Stage IIIB/IV Non-small Cell Lung Cancer
| Autor: | Stinchcombe, Thomas E., Peterman, Amy H., Lee, Carrie B., Moore, Dominic T., Beaumont, Jennifer L., Bradford, Daniel S., Bakri, Kamal, Taylor, Mark, Crane, Jeffrey M., Schwartz, Garry, Hensing, Thomas A., McElroy, Edwin, Jr., Niell, Harvey B., Harper, Harry D., Pal, Sridhar, Socinski, Mark A. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology September 2011 6(9):1569-1577 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|